Superworth

Envoy Medical price to book ratio COCH

Market value divided by the book value of the company's net assets, since 2021.

Today, Nov 2, 2026
15.5×
5-year median
16.1×
Against its 5-year history
44th
percentile: 0 is its lowest day, 100 its highest
5-year range
3.8× to 104×
Peer median
2.4×

Envoy Medical's price to book ratio is 15.5× as of Nov 2, 2026.

That is below its 5-year median of 16.1×, close to the middle of its last 5 years.

Over that time it ranged from 3.8× in Nov 2023 to 104× in Nov 2021.

The median for 7 medical instruments and supplies stocks of a similar size is 2.4×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far15.5×4.8×18.7×
2025n/m a value too high to mean anything
202416.0×4.1×36.8×
20235.7×3.8×7.7×
2022n/m a value too high to mean anything
2021103×102×104×

Against its peers

Companies in Medical - Instruments & Supplies nearest Envoy Medical's size, closest first, today.

CompanyPrice to book ratio
COCHEnvoy Medical15.5×
APTAlpha Pro Tech0.9×
NEPHNephros2.9×
KEQUKewaunee Scientific1.3×
PDEXPro DEX3.7×
UTMDUtah Medical Products1.8×
INFUInfuSystem4.7×
EMBCEmbectan/m
Peer median2.4×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Envoy Medical

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.